Retail Drug

Retail Drug Comprehensive Study by Application (Hospital, Clinic, Hoem Use), Type (Generic Drug, OTC Drug, Others), Drug Type (Cough, Cold, and Flu Products, Analgesics, Vitamins, Mineral, and Supplements (VMS), Dermatology Products, Gastrointestinal Products, Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, Other Product Types) Players and Region - Global Market Outlook to 2028

Retail Drug Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The retail drug is defined as the store which sells both medicines as well as health care products. Customers can easily buy the product from over-the-counter and prescription medication at a drug store. The retail drug has witnessed growth at a noteworthy rate over the past few years due to the rising number of the average age of the consumer and rising aging population across the world is likely to be a major driver for the global retail drug market over the forecast period.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledCVS Caremark (United States), Rite Aid (United States), Target Corporation (United States), Walgreens (United States), Walmart (United States), Health Mart Pharmacy (United States), The Kroger Co. (United States), Good Neighbor Pharmacy (United States), Safeway Inc. (United States), Kmart Corporation (United States) and Hy-Vee (United States)


This growth is primarily driven by Growing Old Age Population and Increasing Health Consciousness across the World and Increasing Disposal Income among Middle-Class Families and Demand for Better Health Care System.

Globally, a noticeable market trend is evident Increasing Number of Customer from Online Drug Retailer The Pharmaceuticals sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as CVS Caremark (United States), Rite Aid (United States), Target Corporation (United States), Walgreens (United States), Walmart (United States), Health Mart Pharmacy (United States), The Kroger Co. (United States), Good Neighbor Pharmacy (United States), Safeway Inc. (United States), Kmart Corporation (United States) and Hy-Vee (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The retail drug market is highly fragmented with the presence of various players. Some of the leading players in the retail drug market are CVS Caremark (United States), Rite Aid (United States), Target Corporation (United States), among others

Influencing Trend:
Increasing Number of Customer from Online Drug Retailer

Market Growth Drivers:
Growing Old Age Population and Increasing Health Consciousness across the World and Increasing Disposal Income among Middle-Class Families and Demand for Better Health Care System

Challenges:
Growing Competition and Consolidation of Retail Pharmacy Chains and Manage Customer Service and Unpleasant Situations in Retail Drug Store

Restraints:
Stringent Government Regulation Regarding Retail Drug Products

Opportunities:
Growing Demand from Emerging Economics such as China, India, Brazil, Philippines, among others and Government Initiative to Promote Retail Drug in Developing Countries

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Retail Drug Market
- Analysis about New Entrants in Retail Drug Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Retail Drug Study Sheds Light on
— The Retail Drug Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Retail Drug industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Retail Drug industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Hospital
  • Clinic
  • Hoem Use
By Type
  • Generic Drug
  • OTC Drug
  • Others

By Drug Type
  • Cough, Cold, and Flu Products
  • Analgesics
  • Vitamins, Mineral, and Supplements (VMS)
  • Dermatology Products
  • Gastrointestinal Products
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Other Product Types

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Indonesia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Old Age Population and Increasing Health Consciousness across the World
      • 3.2.2. Increasing Disposal Income among Middle-Class Families and Demand for Better Health Care System
    • 3.3. Market Challenges
      • 3.3.1. Growing Competition and Consolidation of Retail Pharmacy Chains
      • 3.3.2. Manage Customer Service and Unpleasant Situations in Retail Drug Store
    • 3.4. Market Trends
      • 3.4.1. Increasing Number of Customer from Online Drug Retailer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Retail Drug, by Application, Type, Drug Type and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Retail Drug (Value)
      • 5.2.1. Global Retail Drug by: Type (Value)
        • 5.2.1.1. Generic Drug
        • 5.2.1.2. OTC Drug
        • 5.2.1.3. Others
      • 5.2.2. Global Retail Drug by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
        • 5.2.2.3. Hoem Use
      • 5.2.3. Global Retail Drug by: Type (Value)
        • 5.2.3.1. Generic Drug
        • 5.2.3.2. OTC Drug
        • 5.2.3.3. Others
      • 5.2.4. Global Retail Drug Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Indonesia
          • 5.2.4.2.8. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Retail Drug (Volume)
      • 5.3.1. Global Retail Drug by: Type (Volume)
        • 5.3.1.1. Generic Drug
        • 5.3.1.2. OTC Drug
        • 5.3.1.3. Others
      • 5.3.2. Global Retail Drug by: Application (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Clinic
        • 5.3.2.3. Hoem Use
      • 5.3.3. Global Retail Drug by: Type (Volume)
        • 5.3.3.1. Generic Drug
        • 5.3.3.2. OTC Drug
        • 5.3.3.3. Others
      • 5.3.4. Global Retail Drug Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Indonesia
          • 5.3.4.2.8. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Retail Drug (Price)
  • 6. Retail Drug: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. CVS Caremark (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Rite Aid (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Target Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Walgreens (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Walmart (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Health Mart Pharmacy (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. The Kroger Co. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Good Neighbor Pharmacy (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Safeway Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Kmart Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Hy-Vee (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Retail Drug Sale, by Application, Type, Drug Type and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Retail Drug (Value)
      • 7.2.1. Global Retail Drug by: Type (Value)
        • 7.2.1.1. Generic Drug
        • 7.2.1.2. OTC Drug
        • 7.2.1.3. Others
      • 7.2.2. Global Retail Drug by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
        • 7.2.2.3. Hoem Use
      • 7.2.3. Global Retail Drug by: Type (Value)
        • 7.2.3.1. Generic Drug
        • 7.2.3.2. OTC Drug
        • 7.2.3.3. Others
      • 7.2.4. Global Retail Drug Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Indonesia
          • 7.2.4.2.8. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Retail Drug (Volume)
      • 7.3.1. Global Retail Drug by: Type (Volume)
        • 7.3.1.1. Generic Drug
        • 7.3.1.2. OTC Drug
        • 7.3.1.3. Others
      • 7.3.2. Global Retail Drug by: Application (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Clinic
        • 7.3.2.3. Hoem Use
      • 7.3.3. Global Retail Drug by: Type (Volume)
        • 7.3.3.1. Generic Drug
        • 7.3.3.2. OTC Drug
        • 7.3.3.3. Others
      • 7.3.4. Global Retail Drug Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Indonesia
          • 7.3.4.2.8. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Retail Drug (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Retail Drug: by Type(USD Million)
  • Table 2. Retail Drug Generic Drug , by Region USD Million (2017-2022)
  • Table 3. Retail Drug OTC Drug , by Region USD Million (2017-2022)
  • Table 4. Retail Drug Others , by Region USD Million (2017-2022)
  • Table 5. Retail Drug: by Application(USD Million)
  • Table 6. Retail Drug Hospital , by Region USD Million (2017-2022)
  • Table 7. Retail Drug Clinic , by Region USD Million (2017-2022)
  • Table 8. Retail Drug Hoem Use , by Region USD Million (2017-2022)
  • Table 9. Retail Drug: by Type(USD Million)
  • Table 10. Retail Drug Generic Drug , by Region USD Million (2017-2022)
  • Table 11. Retail Drug OTC Drug , by Region USD Million (2017-2022)
  • Table 12. Retail Drug Others , by Region USD Million (2017-2022)
  • Table 13. South America Retail Drug, by Country USD Million (2017-2022)
  • Table 14. South America Retail Drug, by Application USD Million (2017-2022)
  • Table 15. South America Retail Drug, by Type USD Million (2017-2022)
  • Table 16. South America Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 17. Brazil Retail Drug, by Application USD Million (2017-2022)
  • Table 18. Brazil Retail Drug, by Type USD Million (2017-2022)
  • Table 19. Brazil Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 20. Argentina Retail Drug, by Application USD Million (2017-2022)
  • Table 21. Argentina Retail Drug, by Type USD Million (2017-2022)
  • Table 22. Argentina Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 23. Rest of South America Retail Drug, by Application USD Million (2017-2022)
  • Table 24. Rest of South America Retail Drug, by Type USD Million (2017-2022)
  • Table 25. Rest of South America Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 26. Asia Pacific Retail Drug, by Country USD Million (2017-2022)
  • Table 27. Asia Pacific Retail Drug, by Application USD Million (2017-2022)
  • Table 28. Asia Pacific Retail Drug, by Type USD Million (2017-2022)
  • Table 29. Asia Pacific Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 30. China Retail Drug, by Application USD Million (2017-2022)
  • Table 31. China Retail Drug, by Type USD Million (2017-2022)
  • Table 32. China Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 33. Japan Retail Drug, by Application USD Million (2017-2022)
  • Table 34. Japan Retail Drug, by Type USD Million (2017-2022)
  • Table 35. Japan Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 36. India Retail Drug, by Application USD Million (2017-2022)
  • Table 37. India Retail Drug, by Type USD Million (2017-2022)
  • Table 38. India Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 39. South Korea Retail Drug, by Application USD Million (2017-2022)
  • Table 40. South Korea Retail Drug, by Type USD Million (2017-2022)
  • Table 41. South Korea Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 42. Taiwan Retail Drug, by Application USD Million (2017-2022)
  • Table 43. Taiwan Retail Drug, by Type USD Million (2017-2022)
  • Table 44. Taiwan Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 45. Australia Retail Drug, by Application USD Million (2017-2022)
  • Table 46. Australia Retail Drug, by Type USD Million (2017-2022)
  • Table 47. Australia Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 48. Indonesia Retail Drug, by Application USD Million (2017-2022)
  • Table 49. Indonesia Retail Drug, by Type USD Million (2017-2022)
  • Table 50. Indonesia Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Retail Drug, by Application USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Retail Drug, by Type USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 54. Europe Retail Drug, by Country USD Million (2017-2022)
  • Table 55. Europe Retail Drug, by Application USD Million (2017-2022)
  • Table 56. Europe Retail Drug, by Type USD Million (2017-2022)
  • Table 57. Europe Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 58. Germany Retail Drug, by Application USD Million (2017-2022)
  • Table 59. Germany Retail Drug, by Type USD Million (2017-2022)
  • Table 60. Germany Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 61. France Retail Drug, by Application USD Million (2017-2022)
  • Table 62. France Retail Drug, by Type USD Million (2017-2022)
  • Table 63. France Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 64. Italy Retail Drug, by Application USD Million (2017-2022)
  • Table 65. Italy Retail Drug, by Type USD Million (2017-2022)
  • Table 66. Italy Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 67. United Kingdom Retail Drug, by Application USD Million (2017-2022)
  • Table 68. United Kingdom Retail Drug, by Type USD Million (2017-2022)
  • Table 69. United Kingdom Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 70. Netherlands Retail Drug, by Application USD Million (2017-2022)
  • Table 71. Netherlands Retail Drug, by Type USD Million (2017-2022)
  • Table 72. Netherlands Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 73. Rest of Europe Retail Drug, by Application USD Million (2017-2022)
  • Table 74. Rest of Europe Retail Drug, by Type USD Million (2017-2022)
  • Table 75. Rest of Europe Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 76. MEA Retail Drug, by Country USD Million (2017-2022)
  • Table 77. MEA Retail Drug, by Application USD Million (2017-2022)
  • Table 78. MEA Retail Drug, by Type USD Million (2017-2022)
  • Table 79. MEA Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 80. Middle East Retail Drug, by Application USD Million (2017-2022)
  • Table 81. Middle East Retail Drug, by Type USD Million (2017-2022)
  • Table 82. Middle East Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 83. Africa Retail Drug, by Application USD Million (2017-2022)
  • Table 84. Africa Retail Drug, by Type USD Million (2017-2022)
  • Table 85. Africa Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 86. North America Retail Drug, by Country USD Million (2017-2022)
  • Table 87. North America Retail Drug, by Application USD Million (2017-2022)
  • Table 88. North America Retail Drug, by Type USD Million (2017-2022)
  • Table 89. North America Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 90. United States Retail Drug, by Application USD Million (2017-2022)
  • Table 91. United States Retail Drug, by Type USD Million (2017-2022)
  • Table 92. United States Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 93. Canada Retail Drug, by Application USD Million (2017-2022)
  • Table 94. Canada Retail Drug, by Type USD Million (2017-2022)
  • Table 95. Canada Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 96. Mexico Retail Drug, by Application USD Million (2017-2022)
  • Table 97. Mexico Retail Drug, by Type USD Million (2017-2022)
  • Table 98. Mexico Retail Drug, by Drug Type USD Million (2017-2022)
  • Table 99. Retail Drug Sales: by Type(M Tons)
  • Table 100. Retail Drug Sales Generic Drug , by Region M Tons (2017-2022)
  • Table 101. Retail Drug Sales OTC Drug , by Region M Tons (2017-2022)
  • Table 102. Retail Drug Sales Others , by Region M Tons (2017-2022)
  • Table 103. Retail Drug Sales: by Application(M Tons)
  • Table 104. Retail Drug Sales Hospital , by Region M Tons (2017-2022)
  • Table 105. Retail Drug Sales Clinic , by Region M Tons (2017-2022)
  • Table 106. Retail Drug Sales Hoem Use , by Region M Tons (2017-2022)
  • Table 107. Retail Drug Sales: by Type(M Tons)
  • Table 108. Retail Drug Sales Generic Drug , by Region M Tons (2017-2022)
  • Table 109. Retail Drug Sales OTC Drug , by Region M Tons (2017-2022)
  • Table 110. Retail Drug Sales Others , by Region M Tons (2017-2022)
  • Table 111. South America Retail Drug Sales, by Country M Tons (2017-2022)
  • Table 112. South America Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 113. South America Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 114. South America Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 115. Brazil Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 116. Brazil Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 117. Brazil Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 118. Argentina Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 119. Argentina Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 120. Argentina Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 121. Rest of South America Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 122. Rest of South America Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 123. Rest of South America Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 124. Asia Pacific Retail Drug Sales, by Country M Tons (2017-2022)
  • Table 125. Asia Pacific Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 126. Asia Pacific Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 127. Asia Pacific Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 128. China Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 129. China Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 130. China Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 131. Japan Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 132. Japan Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 133. Japan Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 134. India Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 135. India Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 136. India Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 137. South Korea Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 138. South Korea Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 139. South Korea Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 140. Taiwan Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 141. Taiwan Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 142. Taiwan Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 143. Australia Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 144. Australia Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 145. Australia Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 146. Indonesia Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 147. Indonesia Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 148. Indonesia Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 149. Rest of Asia-Pacific Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 150. Rest of Asia-Pacific Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 151. Rest of Asia-Pacific Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 152. Europe Retail Drug Sales, by Country M Tons (2017-2022)
  • Table 153. Europe Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 154. Europe Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 155. Europe Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 156. Germany Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 157. Germany Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 158. Germany Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 159. France Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 160. France Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 161. France Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 162. Italy Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 163. Italy Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 164. Italy Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 165. United Kingdom Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 166. United Kingdom Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 167. United Kingdom Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 168. Netherlands Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 169. Netherlands Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 170. Netherlands Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 171. Rest of Europe Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 172. Rest of Europe Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 173. Rest of Europe Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 174. MEA Retail Drug Sales, by Country M Tons (2017-2022)
  • Table 175. MEA Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 176. MEA Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 177. MEA Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 178. Middle East Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 179. Middle East Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 180. Middle East Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 181. Africa Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 182. Africa Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 183. Africa Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 184. North America Retail Drug Sales, by Country M Tons (2017-2022)
  • Table 185. North America Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 186. North America Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 187. North America Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 188. United States Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 189. United States Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 190. United States Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 191. Canada Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 192. Canada Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 193. Canada Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 194. Mexico Retail Drug Sales, by Application M Tons (2017-2022)
  • Table 195. Mexico Retail Drug Sales, by Type M Tons (2017-2022)
  • Table 196. Mexico Retail Drug Sales, by Drug Type M Tons (2017-2022)
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Retail Drug: by Type(USD Million)
  • Table 209. Retail Drug Generic Drug , by Region USD Million (2023-2028)
  • Table 210. Retail Drug OTC Drug , by Region USD Million (2023-2028)
  • Table 211. Retail Drug Others , by Region USD Million (2023-2028)
  • Table 212. Retail Drug: by Application(USD Million)
  • Table 213. Retail Drug Hospital , by Region USD Million (2023-2028)
  • Table 214. Retail Drug Clinic , by Region USD Million (2023-2028)
  • Table 215. Retail Drug Hoem Use , by Region USD Million (2023-2028)
  • Table 216. Retail Drug: by Type(USD Million)
  • Table 217. Retail Drug Generic Drug , by Region USD Million (2023-2028)
  • Table 218. Retail Drug OTC Drug , by Region USD Million (2023-2028)
  • Table 219. Retail Drug Others , by Region USD Million (2023-2028)
  • Table 220. South America Retail Drug, by Country USD Million (2023-2028)
  • Table 221. South America Retail Drug, by Application USD Million (2023-2028)
  • Table 222. South America Retail Drug, by Type USD Million (2023-2028)
  • Table 223. South America Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 224. Brazil Retail Drug, by Application USD Million (2023-2028)
  • Table 225. Brazil Retail Drug, by Type USD Million (2023-2028)
  • Table 226. Brazil Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 227. Argentina Retail Drug, by Application USD Million (2023-2028)
  • Table 228. Argentina Retail Drug, by Type USD Million (2023-2028)
  • Table 229. Argentina Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 230. Rest of South America Retail Drug, by Application USD Million (2023-2028)
  • Table 231. Rest of South America Retail Drug, by Type USD Million (2023-2028)
  • Table 232. Rest of South America Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 233. Asia Pacific Retail Drug, by Country USD Million (2023-2028)
  • Table 234. Asia Pacific Retail Drug, by Application USD Million (2023-2028)
  • Table 235. Asia Pacific Retail Drug, by Type USD Million (2023-2028)
  • Table 236. Asia Pacific Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 237. China Retail Drug, by Application USD Million (2023-2028)
  • Table 238. China Retail Drug, by Type USD Million (2023-2028)
  • Table 239. China Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 240. Japan Retail Drug, by Application USD Million (2023-2028)
  • Table 241. Japan Retail Drug, by Type USD Million (2023-2028)
  • Table 242. Japan Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 243. India Retail Drug, by Application USD Million (2023-2028)
  • Table 244. India Retail Drug, by Type USD Million (2023-2028)
  • Table 245. India Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 246. South Korea Retail Drug, by Application USD Million (2023-2028)
  • Table 247. South Korea Retail Drug, by Type USD Million (2023-2028)
  • Table 248. South Korea Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 249. Taiwan Retail Drug, by Application USD Million (2023-2028)
  • Table 250. Taiwan Retail Drug, by Type USD Million (2023-2028)
  • Table 251. Taiwan Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 252. Australia Retail Drug, by Application USD Million (2023-2028)
  • Table 253. Australia Retail Drug, by Type USD Million (2023-2028)
  • Table 254. Australia Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 255. Indonesia Retail Drug, by Application USD Million (2023-2028)
  • Table 256. Indonesia Retail Drug, by Type USD Million (2023-2028)
  • Table 257. Indonesia Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 258. Rest of Asia-Pacific Retail Drug, by Application USD Million (2023-2028)
  • Table 259. Rest of Asia-Pacific Retail Drug, by Type USD Million (2023-2028)
  • Table 260. Rest of Asia-Pacific Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 261. Europe Retail Drug, by Country USD Million (2023-2028)
  • Table 262. Europe Retail Drug, by Application USD Million (2023-2028)
  • Table 263. Europe Retail Drug, by Type USD Million (2023-2028)
  • Table 264. Europe Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 265. Germany Retail Drug, by Application USD Million (2023-2028)
  • Table 266. Germany Retail Drug, by Type USD Million (2023-2028)
  • Table 267. Germany Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 268. France Retail Drug, by Application USD Million (2023-2028)
  • Table 269. France Retail Drug, by Type USD Million (2023-2028)
  • Table 270. France Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 271. Italy Retail Drug, by Application USD Million (2023-2028)
  • Table 272. Italy Retail Drug, by Type USD Million (2023-2028)
  • Table 273. Italy Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 274. United Kingdom Retail Drug, by Application USD Million (2023-2028)
  • Table 275. United Kingdom Retail Drug, by Type USD Million (2023-2028)
  • Table 276. United Kingdom Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 277. Netherlands Retail Drug, by Application USD Million (2023-2028)
  • Table 278. Netherlands Retail Drug, by Type USD Million (2023-2028)
  • Table 279. Netherlands Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 280. Rest of Europe Retail Drug, by Application USD Million (2023-2028)
  • Table 281. Rest of Europe Retail Drug, by Type USD Million (2023-2028)
  • Table 282. Rest of Europe Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 283. MEA Retail Drug, by Country USD Million (2023-2028)
  • Table 284. MEA Retail Drug, by Application USD Million (2023-2028)
  • Table 285. MEA Retail Drug, by Type USD Million (2023-2028)
  • Table 286. MEA Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 287. Middle East Retail Drug, by Application USD Million (2023-2028)
  • Table 288. Middle East Retail Drug, by Type USD Million (2023-2028)
  • Table 289. Middle East Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 290. Africa Retail Drug, by Application USD Million (2023-2028)
  • Table 291. Africa Retail Drug, by Type USD Million (2023-2028)
  • Table 292. Africa Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 293. North America Retail Drug, by Country USD Million (2023-2028)
  • Table 294. North America Retail Drug, by Application USD Million (2023-2028)
  • Table 295. North America Retail Drug, by Type USD Million (2023-2028)
  • Table 296. North America Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 297. United States Retail Drug, by Application USD Million (2023-2028)
  • Table 298. United States Retail Drug, by Type USD Million (2023-2028)
  • Table 299. United States Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 300. Canada Retail Drug, by Application USD Million (2023-2028)
  • Table 301. Canada Retail Drug, by Type USD Million (2023-2028)
  • Table 302. Canada Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 303. Mexico Retail Drug, by Application USD Million (2023-2028)
  • Table 304. Mexico Retail Drug, by Type USD Million (2023-2028)
  • Table 305. Mexico Retail Drug, by Drug Type USD Million (2023-2028)
  • Table 306. Retail Drug Sales: by Type(M Tons)
  • Table 307. Retail Drug Sales Generic Drug , by Region M Tons (2023-2028)
  • Table 308. Retail Drug Sales OTC Drug , by Region M Tons (2023-2028)
  • Table 309. Retail Drug Sales Others , by Region M Tons (2023-2028)
  • Table 310. Retail Drug Sales: by Application(M Tons)
  • Table 311. Retail Drug Sales Hospital , by Region M Tons (2023-2028)
  • Table 312. Retail Drug Sales Clinic , by Region M Tons (2023-2028)
  • Table 313. Retail Drug Sales Hoem Use , by Region M Tons (2023-2028)
  • Table 314. Retail Drug Sales: by Type(M Tons)
  • Table 315. Retail Drug Sales Generic Drug , by Region M Tons (2023-2028)
  • Table 316. Retail Drug Sales OTC Drug , by Region M Tons (2023-2028)
  • Table 317. Retail Drug Sales Others , by Region M Tons (2023-2028)
  • Table 318. South America Retail Drug Sales, by Country M Tons (2023-2028)
  • Table 319. South America Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 320. South America Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 321. South America Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 322. Brazil Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 323. Brazil Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 324. Brazil Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 325. Argentina Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 326. Argentina Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 327. Argentina Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 328. Rest of South America Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 329. Rest of South America Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 330. Rest of South America Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 331. Asia Pacific Retail Drug Sales, by Country M Tons (2023-2028)
  • Table 332. Asia Pacific Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 333. Asia Pacific Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 334. Asia Pacific Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 335. China Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 336. China Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 337. China Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 338. Japan Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 339. Japan Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 340. Japan Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 341. India Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 342. India Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 343. India Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 344. South Korea Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 345. South Korea Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 346. South Korea Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 347. Taiwan Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 348. Taiwan Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 349. Taiwan Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 350. Australia Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 351. Australia Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 352. Australia Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 353. Indonesia Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 354. Indonesia Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 355. Indonesia Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 356. Rest of Asia-Pacific Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 357. Rest of Asia-Pacific Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 358. Rest of Asia-Pacific Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 359. Europe Retail Drug Sales, by Country M Tons (2023-2028)
  • Table 360. Europe Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 361. Europe Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 362. Europe Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 363. Germany Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 364. Germany Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 365. Germany Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 366. France Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 367. France Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 368. France Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 369. Italy Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 370. Italy Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 371. Italy Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 372. United Kingdom Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 373. United Kingdom Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 374. United Kingdom Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 375. Netherlands Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 376. Netherlands Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 377. Netherlands Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 378. Rest of Europe Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 379. Rest of Europe Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 380. Rest of Europe Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 381. MEA Retail Drug Sales, by Country M Tons (2023-2028)
  • Table 382. MEA Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 383. MEA Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 384. MEA Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 385. Middle East Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 386. Middle East Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 387. Middle East Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 388. Africa Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 389. Africa Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 390. Africa Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 391. North America Retail Drug Sales, by Country M Tons (2023-2028)
  • Table 392. North America Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 393. North America Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 394. North America Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 395. United States Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 396. United States Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 397. United States Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 398. Canada Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 399. Canada Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 400. Canada Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 401. Mexico Retail Drug Sales, by Application M Tons (2023-2028)
  • Table 402. Mexico Retail Drug Sales, by Type M Tons (2023-2028)
  • Table 403. Mexico Retail Drug Sales, by Drug Type M Tons (2023-2028)
  • Table 404. Research Programs/Design for This Report
  • Table 405. Key Data Information from Secondary Sources
  • Table 406. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Retail Drug: by Type USD Million (2017-2022)
  • Figure 5. Global Retail Drug: by Application USD Million (2017-2022)
  • Figure 6. Global Retail Drug: by Type USD Million (2017-2022)
  • Figure 7. South America Retail Drug Share (%), by Country
  • Figure 8. Asia Pacific Retail Drug Share (%), by Country
  • Figure 9. Europe Retail Drug Share (%), by Country
  • Figure 10. MEA Retail Drug Share (%), by Country
  • Figure 11. North America Retail Drug Share (%), by Country
  • Figure 12. Global Retail Drug: by Type M Tons (2017-2022)
  • Figure 13. Global Retail Drug: by Application M Tons (2017-2022)
  • Figure 14. Global Retail Drug: by Type M Tons (2017-2022)
  • Figure 15. South America Retail Drug Share (%), by Country
  • Figure 16. Asia Pacific Retail Drug Share (%), by Country
  • Figure 17. Europe Retail Drug Share (%), by Country
  • Figure 18. MEA Retail Drug Share (%), by Country
  • Figure 19. North America Retail Drug Share (%), by Country
  • Figure 20. Global Retail Drug share by Players 2022 (%)
  • Figure 21. Global Retail Drug share by Players (Top 3) 2022(%)
  • Figure 22. Global Retail Drug share by Players (Top 5) 2022(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. CVS Caremark (United States) Revenue, Net Income and Gross profit
  • Figure 25. CVS Caremark (United States) Revenue: by Geography 2022
  • Figure 26. Rite Aid (United States) Revenue, Net Income and Gross profit
  • Figure 27. Rite Aid (United States) Revenue: by Geography 2022
  • Figure 28. Target Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Target Corporation (United States) Revenue: by Geography 2022
  • Figure 30. Walgreens (United States) Revenue, Net Income and Gross profit
  • Figure 31. Walgreens (United States) Revenue: by Geography 2022
  • Figure 32. Walmart (United States) Revenue, Net Income and Gross profit
  • Figure 33. Walmart (United States) Revenue: by Geography 2022
  • Figure 34. Health Mart Pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 35. Health Mart Pharmacy (United States) Revenue: by Geography 2022
  • Figure 36. The Kroger Co. (United States) Revenue, Net Income and Gross profit
  • Figure 37. The Kroger Co. (United States) Revenue: by Geography 2022
  • Figure 38. Good Neighbor Pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 39. Good Neighbor Pharmacy (United States) Revenue: by Geography 2022
  • Figure 40. Safeway Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. Safeway Inc. (United States) Revenue: by Geography 2022
  • Figure 42. Kmart Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 43. Kmart Corporation (United States) Revenue: by Geography 2022
  • Figure 44. Hy-Vee (United States) Revenue, Net Income and Gross profit
  • Figure 45. Hy-Vee (United States) Revenue: by Geography 2022
  • Figure 46. Global Retail Drug: by Type USD Million (2023-2028)
  • Figure 47. Global Retail Drug: by Application USD Million (2023-2028)
  • Figure 48. Global Retail Drug: by Type USD Million (2023-2028)
  • Figure 49. South America Retail Drug Share (%), by Country
  • Figure 50. Asia Pacific Retail Drug Share (%), by Country
  • Figure 51. Europe Retail Drug Share (%), by Country
  • Figure 52. MEA Retail Drug Share (%), by Country
  • Figure 53. North America Retail Drug Share (%), by Country
  • Figure 54. Global Retail Drug: by Type M Tons (2023-2028)
  • Figure 55. Global Retail Drug: by Application M Tons (2023-2028)
  • Figure 56. Global Retail Drug: by Type M Tons (2023-2028)
  • Figure 57. South America Retail Drug Share (%), by Country
  • Figure 58. Asia Pacific Retail Drug Share (%), by Country
  • Figure 59. Europe Retail Drug Share (%), by Country
  • Figure 60. MEA Retail Drug Share (%), by Country
  • Figure 61. North America Retail Drug Share (%), by Country
List of companies from research coverage that are profiled in the study
  • CVS Caremark (United States)
  • Rite Aid (United States)
  • Target Corporation (United States)
  • Walgreens (United States)
  • Walmart (United States)
  • Health Mart Pharmacy (United States)
  • The Kroger Co. (United States)
  • Good Neighbor Pharmacy (United States)
  • Safeway Inc. (United States)
  • Kmart Corporation (United States)
  • Hy-Vee (United States)
Additional players considered in the study are as follows:
Giant Eagl (United States)
Select User Access Type

Key Highlights of Report


May 2023 224 Pages 89 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Retail Drug Quantitative research analysis
Retail Drug Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Retail Drug market are CVS Caremark (United States), Rite Aid (United States), Target Corporation (United States), Walgreens (United States), Walmart (United States), Health Mart Pharmacy (United States), The Kroger Co. (United States), Good Neighbor Pharmacy (United States), Safeway Inc. (United States), Kmart Corporation (United States) and Hy-Vee (United States), to name a few.
North America is dominating the Retail Drug Market.
"Growing Competition and Consolidation of Retail Pharmacy Chains " is seen as one of the major challenges by many Industry Players of Retail Drug Market
The Retail Drug market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Retail Drug market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Retail Drug Report?

Have a Query? Click Here

Other Related Reports

Miconazole Nitrate Comprehensive Study by Type (Oral, Cream), Application (Vaginal Treatment, External Skin Treatment, Oral Treatment), Ingredient (BHA (Beta Hydroxy Acid), BHT (Butylated Hydroxytolu...
$ 3450
Oral Clinical Nutrition Supplements Comprehensive Study by Type (Standard Formula, Specialized Formula), Application (Adult, Geriatric, Paediatric), Form (Liquid, Semi-solid, Powder), Flavors (Chocol...
$ 3450
Domperidone Comprehensive Study by Application (Stomach and bowel, Parkinson's disease, Aids Lactation), Route of Administration (Oral (Mouth), Intramuscular, Intravenous, Rectal), Dosage (Tablets, ...
$ 3650
Cancer API Comprehensive Study by Degib (Sonidegib, Vismodegib), Tinib (Ponatinib, Brigatinib), Rafenib (Sorafenib, Regorafenib, Vemurafenib), Parib (Olaparib, Rucaparib, Niraparib) Players and Regio...
$ 3500
Gynecology Drugs Comprehensive Study by Therapeutics (Hormonal therapy, Non-Hormonal therapy), Prescription Mode (Prescription Based Drugs, OTC Drugs), Indication (Gynecology Cancers, Endometriosis...
$ 3650
Cough Suppressant Drugs Comprehensive Study by Type (Antitussives, Expectorants), Application (Healing of cough, Remedy for Flu), End-User (Hospitals, Diagnostic Clinics, Online Pharmacy, Retail Phar...
$ 3350